intellectual property provisions of the tpp proposals and dangers for access to medicines
DESCRIPTION
TRANSCRIPT
Intellectual Property Provisions of the TPP Proposals and
Dangers for Access to Medicines
Dr. Burcu KilicGlobal Access to Medicines Program
[email protected], 2011
What is Intellectual Property?
• Creations of Mind:– Inventions– Literary and Artistic Works– Symbols and Images used in commerce
• Intellectual Property Rights:– Allow the creator, or owner, of a patent,
trademark or copyright to benefit from his or her own work or investment
Intellectual Property Categories
• Industrial Property– Patents for inventions– Trademarks– Industrial Designs– Geographical Indications
• Copyright– Literary works; novels,
poems and plays– Artistic works; drawings,
paintings, photographs, sculptures and architectural designs
PATENTS
• A patent is an exclusive right to exploit invention, which is a product or a process that provides a new way of doing something, or offers a new technical solution to a problem.
• Patent owner has right to use, sell, licence and exclude others from making, using, distributing selling or importing the invention
• Patents provides 20 years exclusivity to the inventor
Patent Theory
• Patent is a contract between the inventor and the Government
• Inventor agrees to disclose fully (operative) the invention to the public
• In exchange, the Government grants for a “limited time” a “limited monopoly” on the invention to the inventor if certain patentability requirements are met.
What are the patentability requirements?
Patent protection is availablefor invention in all areastechnology provided thatthey fulfil followingrequirements:
• Novelty• Inventive Step• Industrial Applicability
Patentability RequirementsNovelty• Is the claimed invention
disclosed anywhere in the prior art?
WIPO Publication No. 485 (E)
Patentability Requirements
Inventive Step• Even if new and novel, would the claimed invention
have been obvious to one skilled in the art at the time of the invention?
WIPO Publication No.485 (E)
Patentability Requirements
Industrial Applicability• Does the invention
really do anything and, if so, does it solve the problem it is designed to solve?
WIPO Publication No.485 (E)
What cannot be patented?
• Certain inventions are excluded from patentability– inventions that adversely affect public order or
morality – diagnostic, therapeutic and surgical methods for
the treatment of humans or animals are not patentable
– plants and animals (other than microorganisms)
Patents and Pharmaceuticals
• Patents for pharmaceuticals (the TRIPS Agreement)
• Price Increases • Global Crisis in
Access
Pharma vs. Generics• Pharma Industry too
often fails to bring needed drugs to market
• Inadequate record of drug development
• By 2015, $ 200 billion worth of branded drug sales may be lost to generic competition
Pharma vs. Generics
Trans-Pacific Partnership Agreement
• The leaked US proposals for the intellectual property chapter of the TPPA would require significant changes to Malaysian Law, including changes that would limit competition and raise drug prices, thereby restricting access to affordable access to medicines.
Leaked US IP Proposals
Expands pharmaceutical patenting and creatingnew drug monopolies– Ensures patentability for new uses of older,
known drugs and minor variations• Patents for new uses, forms, methods• No exclusions for therapeutic methods of treating humans• Lower “industrial applicability” standard (imposes US utility
standard)
Leaked US IP Proposals
• Adjust patent term for regulatory delays (patent and/or registration)– Allows patent owners to postpone patent expiry. – Delay market entry of generic drugs
• Prevents drug regulatory authority from relying on established data regarding medicine safety and efficacy to register generic medicines for at least 5 years (data exclusivity).
Leaked US IP Proposals
• Links the patent system to drug registration process (patent linkage)
• Favors big pharmaceutical companies in court by requiring courts to –presume any challenged patent valid– weigh the patent holder’s measure of the
value of damages.
What consequences for Access to Medicines?
• Patent protection for many years to come
• Late market entry of generic drugs
• Artificially high drug prices• Restrictions on access to
medicines
Thank You!!
Any Questions?
Dr. Burcu KilicPublic Citizen - Washington, D.C.
[email protected]+1 202 588 1000